Path Traversal in Cisco Duo Device Health Application
CVE-2023-20229
A vulnerability in the CryptoService function of Cisco Duo Device Health Application for Windows could allow an authenticated, local attacker with low privileges to conduct directory traversal attacks and overwrite arbitrary files on an affected system. This vulnerability is due to insufficient input validation. An attacker could exploit this vulnerability by executing a directory traversal attack on an affected host. A successful exploit could allow an attacker to use a cryptographic key to overwrite arbitrary files with SYSTEM-level privileges, resulting in a denial of service (DoS) condition or data loss on the affected system.
Vulnerability class: Path Traversal (Directory Traversal)
Published · last modified .
CVSS v3 metric
CVSS v3 base score 7.1 (High). Vector: CVSS:3.1/AV:L/AC:L/PR:L/UI:N/S:U/C:N/I:H/A:H.
EPSS exploit prediction
EPSS: 0.004 (33.1th percentile), scored .
Very low probability of exploitation in the next 30 days; routine patching cadence is appropriate. 33rd percentile — 33.1% of CVEs in the catalogue have a lower EPSS than this one. How to read EPSS.
EPSS over last 30 days · oldest: 0.004 · newest: 0.004 · change: 0.000
Affected products
- Cisco Duo Device Health Application — versions 5.0.0.0, 5.1.0.0
- Cisco Duo Device Health Application
Weakness classification (CWE)
References
- sec.cloudapps.cisco.com/security/center/content/CiscoSecurityAdvisory/cisco-sa-… (Patch, Vendor Advisory)
Frequently asked questions
- What is CVE-2023-20229?
- CVE-2023-20229 is a high-severity vulnerability in Cisco Duo Device Health Application, classified under Path Traversal. CVSS score: 7.1/10. Published 2023-08-16.
- How severe is CVE-2023-20229?
- High severity. CVSS v3 base score is 7.1 out of 10.